It remains to be investigated which cell types expressing VEGFR1 and VEGFR2 proteins are involved in VEGF-mediated pathology and whether the manipulation of VEGF signaling in specific cell types may attenuate or accelerate the pathological process of AD. This evidence concerns the gene KDR and Alzheimer disease.